UK Markets open in 4 hrs 33 mins

BioPorto A/S (THOXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.75000.0000 (0.00%)
At close: 9:36AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.7500
Open0.7500
BidN/A x N/A
AskN/A x N/A
Day's range0.7500 - 0.7500
52-week range0.3624 - 0.8000
Volume4,000
Avg. volume0
Market cap200.806M
Beta (5Y monthly)1.06
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Notice Convening the Extraordinary General Meeting

    October 22, 2021 Announcement no. 18 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING With reference to company announcement no. 16, the Board of Directors hereby convenes an Extraordinary General Meeting of BioPorto A / S (the “Company”): November 15, 2021, at 3.00 pm (CET), At the Company’s address Tuborg Havnevej 15, st., DK-2900 Hellerup (Parking available in nearby Waterfront Shopping Center) AGENDA AND COMPLETE PROPOSALS: 1) ELECTION OF A NEW MEMBER TO THE BOARD OF DIRECTORS With referen

  • Globe Newswire

    BioPorto A/S appoints new Chief Financial Officer

    October 20, 2021Announcement no. 17 BioPorto A/S appoints new Chief Financial Officer BioPorto A/S (“BioPorto”) today announces the appointment of Neil A. Goldman, CPA as its new Executive Vice President and Chief Financial Officer (CFO). Neil Goldman, a US citizen, joins BioPorto from Chembio Diagnostics, Inc. (NASDAQ:CEMI) (“Chembio”), a global developer and manufacturer of point-of-care tests for infectious disease. At Chembio, Mr. Goldman served as Executive Vice President and CFO, during wh

  • Globe Newswire

    BioPorto A/S appoints new Chief Executive Officer and announces changes to the Board of Directors

    October 20, 2021Announcement no. 16 BioPorto A/S appoints new Chief Executive Officer and announces changes to the Board of Directors BioPorto A/S (“BioPorto”) has announced the appointment of Anthony Pare as its new Chief Executive Officer (CEO). Anthony (Tony) Pare, a US citizen, will join BioPorto directly from T2 Biosystems, a US Nasdaq-listed in vitro diagnostics company, where he served as the Chief Commercial Officer and presided over several successful product launches. He will start in